Consistent with CXCR4 being a negative prognostic marker in CLL,27 we observed higher expression levels of surface CXCR4 on the bulk population of progressing patients and a trend for higher levels of CD5 (p = 0.07; Figure 5B). The gene discussed is CXCR4; the disease is B-cell chronic lymphocytic leukemia.